Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy

Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2013Yazar
Zorlu, MehmetKıskaç, Muharrem
Karatoprak, Cumali
Çakırca, Mustafa
Yavuz, Erdinç
Çetin, Güven
Çıkrıklıoğlu, Mehmet Ali
Üst veri
Tüm öğe kaydını gösterKünye
Zorlu, M., Kıskaç, M., Karatoprak, C., Çakırca, M., Yavuz, E., Çetin, G., Çıkrıkçıoğlu, MA. (2013). Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy. Indian Journal of Pharmacology, 45(6), 631-633.Özet
Methotrexate (MTX) may have adverse effects on multiple organs and system. A few cases of pulmonary tuberculosis in-patients with rheumatoid arthritis (RA) while receiving MTX monotherapy has been reported in the literature. We submit a case of vertebral tuberculosis with hypercalcemia in a patient receiving MTX monotherapy. Patient with RA taking MTX for 15 years developed pancytopenia, skin necrosis, tuberculous spondylodiscitis and hypercalcemia. the present case showed adverse effects of MTX therapy may occur even after years of continuous treatment. Due to pancytopenia in older patients, life-threatening tuberculosis at unusual sites may develop.